Lessons Learned in Clinical Decision Support: Overalerting - PowerPoint PPT Presentation

1 / 25
About This Presentation
Title:

Lessons Learned in Clinical Decision Support: Overalerting

Description:

Overall alert acceptance higher at tiered site (29% vs 10%, p .001) ... Streamlined knowledge bases and tiered alerting have higher acceptance rates ... – PowerPoint PPT presentation

Number of Views:58
Avg rating:3.0/5.0
Slides: 26
Provided by: davidwb7
Category:

less

Transcript and Presenter's Notes

Title: Lessons Learned in Clinical Decision Support: Overalerting


1
Lessons Learned in Clinical Decision Support
Over-alerting
  • Tejal K. Gandhi, MD MPH
  • Director of Patient Safety
  • Brigham and Womens Hospital
  • Assistant Professor in Medicine
  • Harvard Medical School

2
Overriding of Alerts
  • Studies have shown that MDs override clinical
    decision support alerts a large percent of the
    time
  • 88 of inpatient DDI alerts overridden (Payne et
    al. Proc AMIA 2002)
  • 83 of inpatient drug-allergy alerts (Abookire et
    al. Proc AMIA 2000)
  • 89 of outpatient high severity DDI alerts and
    91 of outpatient drug-allergy alerts (Weingart
    et al. Arch Intern Med 2003)

3
Are Overrides Appropriate?
  • 7,761 drug-allergy alerts in BWH inpatients,
    Aug-Oct 2002
  • Alerts were overridden 80 of the time
  • In chart review of 300 overrides, all were
    clinically justified
  • Evidence that we are over-alerting
  • Only 6 of alerts were triggered by an exact
    match between drug ordered and drug in allergy
    list (lots of potential noise)

Hsieh et al. JAMIA 2004
4
Alerts Triggered by Exact Drug-Allergy Matches
are Rare
  • Ordered drug
  • Hydromorphone (DILAUDID) (N18)
  • Drug in allergy list
  • Codeine (39)
  • Oxycodone (22)
  • Meperidine (22)
  • Morphine (17)
  • Hydromorphone (0)

5
Alerts Triggered by Exact Drug-Allergy Matches
are Rare
  • Ordered drug
  • Furosemide (LASIX) (N18)
  • Hydrochlorothiazide (N4)
  • Drug in allergy list
  • Sulfa (95)
  • Furosemide (5)
  • Sulfa (100)
  • Hydrochlorothiazide (0)

6
Allergy Alerting Recommendations
  • Need better specificity of alerts to avoid false
    positives
  • E.g. requiring exact matches for certain classes
  • Good news FDB recently removed lasix/HCTZ
    sulfa interaction

7
Overall Alerting Issues
  • Need more studies to maximize effectiveness of
    alerts/ minimize over-alerting
  • Issue of how best to display the messages
  • Need to learn from other industries (industrial
    engineering)

8
Drug-Pregnancy Level 1
9
(No Transcript)
10
Potential Strategies to Improve Alerting
  • Creation of streamlined knowledge bases
  • Only essential content
  • Balance between sensitivity and specificity
  • Tiering of alerts is also a possibility
  • Hard stop
  • Interruptive
  • Non-interruptive
  • Minimizing interruptions

11
Impact of Reduced Alerting on Override Rates
  • Study in the ambulatory setting
  • Decision support included
  • Duplicate drug
  • Drug-disease
  • Drug-drug
  • Drug-lab
  • Drug-pregnancy

Shah et al. JAMIA 2006
12
Knowledge base streamlining
  • Expert panel
  • Physicians, pharmacists, informaticians
  • Reviewed sources
  • Vendor knowledge-bases, pre-existing locally
    created KBs, literature
  • Removed certain alerts and tiered the rest

13
Alert tiers
  • Level 1 Potentially life-threatening
  • E.g., erythromycin - diltiazem -gt V-fib
  • Hard stop couldnt proceed
  • Level 2 Potential for serious injury
  • Rizatriptan - linezolid -gt serotonin syndrome
  • Interruptive, required a reason
  • Level 3 Use w/ caution
  • Warfarin levofloxacin -gt increased PT
  • Noninterruptive

14
(No Transcript)
15

16
Actions w/ level 2 alerts
  • Cancel
  • Do not proceed with order
  • Modify, examples include
  • Alter the problem list
  • Discontinue the pre-existing drug
  • Hold the other medication
  • Accept defined as cancel or modify
  • Override defined as not accept

17
Results
  • Final knowledge base
  • 2 level 1 63 level 2, 35 level 3
  • 18,115 alerts
  • 12,933 non-interruptive (71)
  • 5,182 interruptive (29)
  • Of 5,182 interruptive alerts
  • 3475 (67) accepted

18
Interruptive alerts
19
Summary of Reduced Alerting Study
  • Can reduce alert burden by streamlining and
    tiering the knowledge base
  • Concept of a non-interruptive alert may be
    helpful
  • Still need more research on what is optimal level
    of alerting
  • Are we missing things is always the worry

20
Non-interruptive alerts
21
(No Transcript)
22
Impact of Non-Interruptive Alerts
  • Drilled down into the drug-lab alerts
  • No difference in lab ordering between control and
    intervention groups
  • Is it a user interface issue or are
    non-interruptive alerts just not effective?
  • Cost- benefit issue
  • Minimize interruptions so higher risk alerts are
    accepted more often yet little benefit seen with
    non-interruptive alerts

23
Impact of Tiering on Inpatient DDI Alerts
  • Two academic medical centers
  • Same knowledge base
  • Site A used 3 tiers
  • Site B had all of the alerts as interruptive
    (Level 2)
  • Overall alert acceptance higher at tiered site
    (29 vs 10, plt.001)

Paterno, et al. Unpublished data.
24
Tiered Inpatient DDI Acceptance Rates
  • Level 1 Acceptance rates
  • 100 (hard stop) vs 34 (not a hard stop)
  • Level 2 Acceptance rates
  • 29 vs 11
  • Likely higher at tiered site since less alert
    fatigue because fewer interruptive alerts

25
Conclusions
  • Streamlined knowledge bases and tiered alerting
    have higher acceptance rates
  • Especially for very high risk alerts
  • Non-interruptive alerts may have little value
  • What is our ideal acceptance rate??
    Sensitivity/specificity? Best way to display?
  • More work needs to be done to maximize the
    clinical benefits
  • Sharing of streamlined knowledge should be
    widespread
  • No need to reinvent the wheel
Write a Comment
User Comments (0)
About PowerShow.com